Find information on thousands of medical conditions and prescription drugs.

Brevibloc

Esmolol (tradename Brevibloc®) is a cardioselective beta1 receptor blocker with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane stabilising activity at therapeutic dosages. more...

Home
Diseases
Medicines
A
B
Baciim
Bacitracin
Baclofen
Bactrim
Bactroban
Barbexaclone
Barbital
Baros
Basiliximab
Baycol
Beclamide
Beclometasone
Beclovent
Beconase
Beldin
Benadryl
Benazepril
Bendroflumethiazide
Benserazide
Bentiromide
Benylin
Benzaclin
Benzalkonium chloride
Benzocaine
Benzonatate
Betacarotene
Betadine
Betahistine
Betamethasone
Betaxolol
Bextra
Biaxin
Bibrocathol
Bicalutamide
Bicillin
Biclotymol
Biotin
Bisoprolol
Bleomycin
Blocadren
Boldenone
Boniva
Bontril
Bosentan
Bravelle
Brethaire
Brevibloc
Brevicon
Bricanyl
Bromazepam
Bromelain
Bromhexine
Bromocriptine
Brompheniramine
Bronkodyl
Bronopol
BSS
Bucet
Budesonide
Bumetanide
Bupivacaine
Buprenex
Buprenorphine
Buserelin
Buspar
Buspirone
Busulfan
Butalbital
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Esmolol decreases the force and rate of heart contractions by blocking beta-adrenergic receptors of the sympathetic nervous system, which are found in the heart, lungs and other organs of the body. Esmolol prevents the action of two naturally occurring substances: epinephrine and norepinephrine.

Dosing

Esmolol is given by slow intravenous injection. It is commonly used in patients during surgery to prevent or treat tachycardia, and is also used in treatment of supraventricular tachycardia.

Metabolism

Esmolol is rapidly hydrolysed by the esterases in the cytosol of red blood cells. Plasma cholinesterases and red cell membrane acetylcholinesterase do not have any action. This metabolism results in the formation of a free acid and methanol. The amount of methanol produced is similar to endogenous methanol production. Its elimination half-life is about 9 minutes.


Read more at Wikipedia.org


[List your site here Free!]


Undiluted error
From Nursing, 6/1/98 by Cohen, Michael R

A patient recently died when a physician accidentally injected a 25-fold overdose of esmolol (Brevibloc). He administered the entire contents of a 10 ml ampule (2.5 grams) instead of a 10 ml (100 mg) vial for a loading dose. How did this happen?

The manufacturer had affixed a label, Amp must be diluted, to the ampule's neck, but this warning didn't prevent a communication breakdown. The nurse drew up the ampule's contents into a syringe and handed it to the physician, assuming that he'd further dilute it in an I.V. bag. Instead, he injected the syringe contents directly into the patient's I.V. line. The massive overdose caused an immediate cardiac arrest.

We're aware of at least 30 deaths or serious injuries associated with the ampule form of the drug. We've previously contacted the drug's manufacturer, Ohmeda, and the FDA about this problem, and the manufacturer is working to repackage the drug in a premixed form.

Copyright Springhouse Corporation Jun 1998
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Brevibloc
Home Contact Resources Exchange Links ebay